Vaccine hesitancy among general practitioners in Southern France and their reluctant trust in the health authorities

Wilson, Rose; Vergélys, Chantal; Ward, Jeremy K.; Peretti‐Watel, Patrick; Verger, Pierre

doi:10.1080/17482631.2020.1757336

Cited by 46 publications

(48 citation statements)

References 46 publications

(54 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These differences were at least partly expected on account of the different degree of penetrance of COVID-19 vaccine among healthcare workers, which was reported as significantly lower in France, in particular in Paris 18 , 19 , 20 , than in Italy. In fact, in 2016, France and Italy were the two countries with the highest rates of vaccine safety skepticism 21 A European study conducted in April 2020 in seven countries showed that France had the largest proportion of the population opposed to a COVID-19 vaccine (10%) and the largest group of people who had not decided whether or not they would be vaccinated (28%).…”

Section: Discussionmentioning

confidence: 90%

“…In this regard, while we agree that from an ethical point of view, information campaigns are important for supporting choices, we have come to think that they may be less relevant than confidence in the role of science, a term that was chosen to indirectly allude to the medical community. Lack of confidence in the healthcare system was in fact identified as a major determinant of vaccine hesitancy in the case of COVID-19 and of other vaccines 10 , 19 , 26 , 27 , 28 , and the low vaccine acceptance of healthcare workers in some “difficult” settings may also be evidence of this attitude.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France

Blanchi¹,

Torreggiani²,

Chatrenet³

et al. 2021

Kidney International Reports

View full text Add to dashboard Cite

Introduction Patients on dialysis (HDP) are a category at high risk from COVID-19 and thus a high-priority group for vaccination. COVID-19 vaccine hesitancy has been a concern since the availability of the first vaccine. The objective of this study was to determine hesitancy rates and factors associated with hesitancy towards COVID-19 vaccination in HDP. Methods HDP were surveyed with an ad hoc questionnaire in four large dialysis facilities in Europe: Le Mans and Paris, in France, Cagliari and Pavia, in Italy. The questionnaire explored different domains associated with vaccine hesitancy, such as perception of disease severity, sources of information about the vaccine and the disease, and confidence in the healthcare system. Results 417 patients (average age 69, 60% men) agreed to answer the questionnaire. Hesitancy was associated with younger age (p 0.003), lower perception of disease severity (<0.001) and vaccine efficacy (p<0.001), lower trust in vaccination (p<0.001) and in the healthcare system and scientists (p<0.001) in the univariate analysis. In the multivariate models, concerns about side effects (p 0.004) and vaccine efficacy (<0.001) and living in France (p 0.04) remained associated with higher vaccine hesitancy, while having received an influenza vaccine (p 0.032) and trusting scientists (p 0.032) were associated with a more positive attitude towards vaccination. Conclusions HDP have a good understanding of the risks associated with COVID-19. Vaccine hesitancy was not associated with educational level, age or gender but rather with lack of confidence in vaccine efficacy and concerns about safety. HDP were quite skeptical about the healthcare system but generally trusted scientists.

show abstract

Section: Discussionmentioning

confidence: 90%

Section: Discussionmentioning

confidence: 99%

COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France

Blanchi¹,

Torreggiani²,

Chatrenet³

et al. 2021

Kidney International Reports

View full text Add to dashboard Cite

show abstract

“…However, several challenges face the GVAP goal to increase the voluntary vaccination against influenza, particularly vaccine hesitancy. This has been faced with almost all vaccines before, such as diphtheria-tetanus-pertussis and hemophilus influenza [ 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 ]. Even in light of the recent COVID-19 pandemic, many remain skeptical and intend to abstain from voluntary vaccinations based upon myths, misinformation, and/or safety concerns [ 10 , 11 , 12 , 13 , 14 ].…”

Section: Introductionmentioning

confidence: 99%

Public Knowledge, Attitudes, and Practices toward Seasonal Influenza Vaccine in Saudi Arabia: A Cross-Sectional Study

Sales

Wajid

Almutairi

et al. 2021

IJERPH

View full text Add to dashboard Cite

Objectives: Increasing national influenza vaccination rates continues to be a challenge for Saudi Arabia. Therefore, the purpose of this study was to explore the Saudi public perceptions toward seasonal influenza vaccination and their association with the rate of vaccination. Methods: Individuals aged 15 years and older were surveyed about their knowledge, attitudes, and practices toward the seasonal influenza vaccine using a previously developed and validated 19-item online questionnaire. The impact of the participants’ perceptions toward the seasonal influenza vaccine on their past influenza vaccination history was assessed using multiple linear regressions. Results: The rate of regular vaccination among the 790 surveyed participants was 12.65%, and those who were aged <24 years had the highest rate (57%). The vast majority of the participants with chronic diseases (>90%) reported irregular vaccination histories against seasonal influenza. Participants who believed that the influenza vaccine is safe (β = 3.27; 95% CI: 2.067 to 5.171; p <0.001), efficacious (β = 2.87; 95% CI: 1.834 to 4.498; p <0.001), should be given during a specific time in the year (β = 1.821; 95% CI: 1.188 to 2.789; p = 0.0059), and were aware of their need to get vaccinated against the seasonal influenza (β = 2.781; 95% CI: 1.254 to 6.188; p = 0.0119) were more likely to have received the vaccine. Conclusion: The findings of this study suggest that the rate of seasonal influenza vaccination is low among the Saudi population, which necessitates the launching of public awareness campaigns about the importance of the seasonal influenza vaccine.

show abstract

“…From Table A1 we knew that the most trusted source of information was a general practitioner, a doctor, or a pediatrician (79.1% of the total responses). Several investigations showed that a significant share of health care providers is vaccine-hesitant [51][52][53][54][55]. Even though few health care providers are openly against vaccines, many of them find conversations about vaccines with vaccine-hesitant people to be difficult and unproductive [52].…”

Section: Discussionmentioning

confidence: 99%

Global Vaccine Hesitancy Segmentation: A Cross-European Approach

2021

View full text Add to dashboard Cite

Vaccine-preventable diseases are global mainly in a globalized world that is characterized by a continuous movement of people and goods across countries. Vaccine hesitancy, the reluctance or refusal to vaccinate despite the availability of vaccines, is rising worldwide. What if the problem of vaccine hesitancy could be most effectively managed when treated globally rather than on a national or regional basis? What if a global vaccine-hesitant segment exists and the differences among countries are not so significant? Based on the Global Marketing Strategy paradigm, this paper shows that seven different cross-European segments exist based on the beliefs, attitudes, and behaviors collected in 28 European countries. These pan-European segments are differentiable (people in those segments have similar characteristics that are visibly dissimilar from the ones in other segments) and actionable (organizations would be able to propose interventions to the hesitant segments based on their profiles). With segmentation being the starting point of many public health intervention strategies for avoiding vaccine-hesitancy, the results recommend moderating the full-adaptation strategy that follows the “context matters” principle suggested by several political and public health international organizations. Embracing a more standardized strategy will allow the development of better services and strategies that support and enable desirable vaccination behaviors.

show abstract

Vaccine hesitancy among general practitioners in Southern France and their reluctant trust in the health authorities

Cited by 46 publications

References 46 publications

COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France

COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France

Public Knowledge, Attitudes, and Practices toward Seasonal Influenza Vaccine in Saudi Arabia: A Cross-Sectional Study

Global Vaccine Hesitancy Segmentation: A Cross-European Approach

Contact Info

Product

Resources

About